Shilpa Medicare Limited operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shilpa Medicare Limited with three other
companies in this sector in India:
Sms Pharmaceuticals Limited
sales of 6.54 billion Indian Rupees [US$98.26 million]
of which 100%
Ttk Healthcare Limited
(5.33 billion Indian Rupees [US$80.07 million]
of which 52%
was Pharmaceuticals), and
Advanced Enzyme Technologies Ltd
(3.31 billion Indian Rupees [US$49.80 million]
Shilpa Medicare Limited reported sales of 7.79 billion Indian Rupees (US$117.07 million)
March of 2017.
increase of 8.3%
versus 2016, when the company's sales were 7.19 billion Indian Rupees.
Sales at Shilpa Medicare Limited have increased during each of the previous five years
(and since 2012, sales have increased a total of 145%).